Background information on HIV, hepatitis C and STIs in Canada, including basic information, statistics (epidemiology), provincial and national strategies to address HIV, hepatitis C and STIs, and social determinants of health.
Information on HIV and hepatitis C transmission and prevention, including STIs and safer sex, harm reduction, pregnancy and infant feeding, and microbicides and vaccines.
Information on diagnostic tests for HIV, hepatitis C and STIs; the delivery of testing and counselling; and resources for people who are newly diagnosed.
Information on treatment, care and support for HIV, hepatitis C and STIs, including medications, healthy living, pregnancy and infant feeding, hepatitis C re-infection, and long-term health issues.
CATIE’s online educational courses, webinars, online and print publications, and other websites.
CATIE strengthens Canada’s response to HIV and hepatitis C by bridging research and practice. We connect healthcare and community-based service providers with the latest science, and promote good practices for prevention and treatment programs.
If you inject drugs and share needles or other equipment, maintaining an undetectable viral load lowers the chance of passing HIV. However, we don’t know exactly how much the chance of passing HIV is reduced.
It is best to use new equipment each time you inject drugs, to prevent passing HIV and other infections such as hepatitis B and C.
